Structure Therapeutics Inc. (GPCR)
Nasdaq: GPCR · Pharmaceutical Preparations · South San Francisco, CA · filing with the SEC since 2021
Income statement, as filed
In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts in thousands. The fiscal year ends in December.| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Period ending | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 |
| Report filed | Feb 26, 2026 | Feb 27, 2025 | Mar 8, 2024 | Mar 30, 2023 |
| Research and development | 225,255 | 108,814 | 70,103 | 36,193 |
| General and administrative | 61,554 | 49,414 | 32,672 | 16,368 |
| Total operating expenses | 176,560 | 158,228 | 102,775 | 52,561 |
| Operating income | -176,560 | -158,228 | -102,775 | -52,561 |
| Income before income taxes | -140,687 | -122,216 | -89,384 | -51,304 |
| Income tax expense | 515 | 310 | 236 | 17 |
| Net income including non-controlling interests | -141,202 | -122,526 | -89,620 | -51,321 |
| Net income | -141,202 | -122,526 | -89,620 | -51,321 |
| Net income to common shareholders | · | · | -89,620 | -52,836 |
| Earnings per share, basic | -0.80 | -0.78 | -0.81 | -5.51 |
| Earnings per share, diluted | -0.80 | -0.78 | -0.81 | -5.51 |
| Weighted average shares, basic | 177,596 | 157,922 | 110,198 | 9,584 |
| Weighted average shares, diluted | 177,596 | 157,922 | 110,198 | 9,584 |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Research and development spent on inventing what it sells next
us-gaap:ResearchAndDevelopmentExpenseGeneral and administrative the cost of running the company itself
us-gaap:GeneralAndAdministrativeExpenseTotal operating expenses the running costs together
us-gaap:OperatingExpensesOperating income profit from running the business, before interest and tax
us-gaap:OperatingIncomeLossIncome before income taxes profit before tax
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestIncome tax expense tax charged on the period's profit
us-gaap:IncomeTaxExpenseBenefitNet income including non-controlling interests the whole group's profit, minority holders' share included
us-gaap:ProfitLossNet income the profit or loss that belongs to the company's shareholders
us-gaap:NetIncomeLossNet income to common shareholders what is left for common shareholders
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasicEarnings per share, basic net income per share outstanding
us-gaap:EarningsPerShareBasicEarnings per share, diluted net income per share, counting every share that could be issued
us-gaap:EarningsPerShareDilutedWeighted average shares, basic the average count of shares outstanding
us-gaap:WeightedAverageNumberOfSharesOutstandingBasicWeighted average shares, diluted the average count with every share that could be issued
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding